← Back to Search

Remote Blood Pressure Monitoring for Postpartum Women (SMART-BP Trial)

N/A
Recruiting
Led By Elizabeth T Jensen, MPH PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up discharge through 12 months postpartum
Awards & highlights

SMART-BP Trial Summary

This trial is testing whether or not checking a woman's blood pressure remotely for 3 weeks after childbirth is an effective way to monitor BP without having to extend their hospital stay.

Who is the study for?
This trial is for women over 18 in Forsyth County, NC who've recently given birth and received postpartum care at The Birth Center at Atrium Health Wake Forest Baptist. Participants need daily access to a smartphone with Wi-Fi or data and must be able to read English or Spanish.Check my eligibility
What is being tested?
The study tests if monitoring blood pressure using a smart phone app, BabyScripts™, along with remote BP cuff instructions can effectively track BP levels in new mothers for three weeks after leaving the hospital.See study design
What are the potential side effects?
There are no direct side effects from participating as it involves non-invasive blood pressure monitoring. However, there may be indirect consequences such as anxiety from self-monitoring or data privacy concerns.

SMART-BP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

SMART-BP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~discharge through 12 months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and discharge through 12 months postpartum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Median number of Severe Hypertension events
Median number of rBPM measures obtained
Median total cost of health care
+1 more
Secondary outcome measures
Acceptability of rBPM in postpartum period
Median Length of Stay (LOS) for hospital readmissions
Median Length of Stay (LOS) in hospital after delivery
+3 more
Other outcome measures
Validate and calibrate previously developed predictive algorithm

SMART-BP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Remote Blood Pressure Monitoring (rBPM)Experimental Treatment3 Interventions
Subjects randomized to rBPM arm receive the appropriate standard of care depending upon their risk level, as well as the remote BP monitoring app (BabyScripts) and Bluetooth enabled BP cuff/monitor, and will receive the following equipment and monitoring: a specialized, Bluetooth enabled BP monitoring cuff (Clinically Validated, A&D Medical Wireless Blood Pressure Monitor-Upper Arm (Appendix 2) BP monitoring smart phone app, BabyScripts™ Verbal and written instructions, to conduct BP checks at home
Group II: Standard of Care (SOC)Active Control1 Intervention
Subjects randomized to SOC arm are provided with the appropriate standard of care depending upon their risk level (as determined by their individual provider or WFBMC Maternal-Fetal Medicine provider)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Instructions
2021
N/A
~110

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,241 Previous Clinical Trials
1,002,487 Total Patients Enrolled
Elizabeth T Jensen, MPH PhDPrincipal InvestigatorAtrium Health Wake Forest Baptist

Media Library

Blood Pressure (BP) monitoring smart phone app, BabyScripts™ Clinical Trial Eligibility Overview. Trial Name: NCT05236725 — N/A
High Blood Pressure Research Study Groups: Standard of Care (SOC), Remote Blood Pressure Monitoring (rBPM)
High Blood Pressure Clinical Trial 2023: Blood Pressure (BP) monitoring smart phone app, BabyScripts™ Highlights & Side Effects. Trial Name: NCT05236725 — N/A
Blood Pressure (BP) monitoring smart phone app, BabyScripts™ 2023 Treatment Timeline for Medical Study. Trial Name: NCT05236725 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are being recruited for this experiment?

"Confirmatively, clinicaltrials.gov reveals that this medical experiment is actively seeking participants; it was first advertised on March 1st 2022 and the details were most recently revised on March 30th 2022. For successful completion of this trial, 3500 patients must be found from a single site."

Answered by AI

Are there currently any openings for participants to join this experiment?

"Per the information on clinicaltrials.gov, this experiment is still in need of enrollees. This research was initially published on March 1st 2022 and has been recently amended as of March 30th 2021."

Answered by AI
~233 spots leftby Sep 2024